Luke W. ASHCRAFT,Gustave BERGNES,Scott COLLIBEE,Chihyuan CHUANG,Jeff GARDINA,Bradley P. MORGAN,Alex R. MUCI,Xiangping QIAN,Jeffrey WARRINGTON,Zhe YANG,Pu-Ping LU,Antonio ROMERO
申请号:
US15463288
公开号:
US20170281621A1
申请日:
2017.03.20
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Provided are compounds of Formula I:or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and m are as defined herein.Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.